Tech Titans Investing Millions to Create Genetically Engineered Babies
By Tina Stevens,
CounterPunch
| 12. 11. 2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter Theil and Reddit founder Alexis Ohanian are supplying lavish funds to explore human embryo gene editing and to market “polygenic” (i.e., multi-gene) screening of embryos for quality control.
While their brassy business models boast the goal of eliminating diseases (for which other less risky interventions are available), skeptical experts can sniff an agenda that is peddled more discretely: engineering children to “enhance” traits such as eye color, height, intelligence, and athletic ability. UC Berkeley scientist Fyodor Urnov’s critique is decisive. “These people armed with very poorly deployed sacks of cash are working on “baby improvement,” he said. University of Virginia behavioral geneticist Eric Turkheimer characterized the marketing of unproven probabilistic screening methods as “corporate eugenics.”
Even when disassociated from the eugenic savagery of WWII Nazi Germany, the tech titans’ “techno eugenics” hasten the arrival of bio-entrepreneurially created societies of...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...